A drug with the SMILES Cc1cn(C(=O)c2ccccc2)c(=S)n1-c1ccc(Br)cc1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 17.525%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1cn(C(=O)c2ccccc2)c(=S)n1-c1ccc(Br)cc1
Cc1cn(C(=O)c2ccccc2)c(=S)n1-c1ccc(Br)cc1
[3-(4-bromophenyl)-4-methyl-2-sulfanylideneimidazol-1-yl]-phenylmethanone